Difference between revisions of "Herbal Drugs"
(New page: According to a study in the ''British Medical Journal'': :Sales of herbal medicines are booming. This is particularly true in the United States, where the market for herbal supplements is...) |
|||
| Line 2: | Line 2: | ||
:Sales of herbal medicines are booming. This is particularly true in the United States, where the market for herbal supplements is now approaching $4bn a year. The fastest growth has been recorded for St John's wort, a herbal antidepressant whose sales increased in one year by 2800%<ref>E. Ernst, [http://www.bmj.com/cgi/content/full/321/7258/395 Herbal medicines: where is the evidence?], British Medical Journal, BMJ 2000;321:395-396 ( 12 August )</ref>. | :Sales of herbal medicines are booming. This is particularly true in the United States, where the market for herbal supplements is now approaching $4bn a year. The fastest growth has been recorded for St John's wort, a herbal antidepressant whose sales increased in one year by 2800%<ref>E. Ernst, [http://www.bmj.com/cgi/content/full/321/7258/395 Herbal medicines: where is the evidence?], British Medical Journal, BMJ 2000;321:395-396 ( 12 August )</ref>. | ||
| + | |||
| + | ==Resources== | ||
| + | |||
| + | *Brevoort P. The booming US botanical market. A new overview. Herbalgram 1998; 44: 33-46. | ||
| + | *Linde K, Ramirez G, Mulrow CD, Pauls A, Weidenhammer W, Melchart D. St John's wort for depression: an overview and meta-analysis of randomised clinical trials. BMJ 1996; 313: 253-258[Abstract/Free Full Text]. | ||
| + | *Stevinson C, Ernst E. Hypericum for depression: an update of the clinical evidence. Eur Neuropharmacol (in press). | ||
| + | *Ernst E, Pittler MH. Ginkgo biloba for dementia: a systematic review of double-blind, placebo-controlled trials. Clin Drug Invest 1999; 17: 301-308. | ||
| + | *Wilt TJ, Iskani A, Stark G, McDonald R, Lan J, Murlow C. Saw palmetto extracts for treatment of benign prostatic hyperplasia. JAMA 1998; 280: 1604-1609[Abstract/Free Full Text]. | ||
| + | *Pittler MH, Ernst E. Horse-chestnut seed extract for chronic venous insufficiency: a criteria-based systematic review. Arch Dermatol 1998; 134: 1356-1360[Abstract/Free Full Text]. | ||
| + | *Müller WE, Singer A, Wonnemann M, Hafner U, Schäfer C. Hyperforin represents the neurotransmitter uptake inhibiting constituent of hypericum extract. Pharmacopsychiat 1998; 31(suppl): 16-21. | ||
| + | *Jowell T. Herbal medicines. In: House of Commons official report (Hansard) , 1999 March 26;426-27. | ||
| + | *Lord GM, Tagore R, Cook T, Gower P, Pusey CD. Nephropathy caused by Chinese herbs in the UK. Lancet 1999; 354: 481-482[CrossRef][Medline]. | ||
| + | *Chrubasik S, Sporner F, Wink M. Zum Wirkstoffgehalt in Arzneimitteln aus Hapargophytum procumbens. Forsch Komplementärmed 1996; 3: 57-63. | ||
| + | *Keane FM, Munn SE, du Vivier AWP, Taylor NF, Higgins EM. Analysis of Chinese herbal creams prescribed for dermatological conditions. BMJ 1999; 318: 563-564[Abstract/Free Full Text]. | ||
| + | *Janetzky K, Morreale AP. Probable interactions between warfarin and ginseng. Am J Health Syst Pharm 1997; 54: 692-693[Free Full Text]. | ||
| + | *Ernst E. Possible interactions between synthetic and herbal medicinal products. Part 1: a systematic review of the indirect evidence. Perfusion (in press). | ||
==Notes== | ==Notes== | ||
Latest revision as of 17:35, 29 January 2010
According to a study in the British Medical Journal:
- Sales of herbal medicines are booming. This is particularly true in the United States, where the market for herbal supplements is now approaching $4bn a year. The fastest growth has been recorded for St John's wort, a herbal antidepressant whose sales increased in one year by 2800%[1].
Resources
- Brevoort P. The booming US botanical market. A new overview. Herbalgram 1998; 44: 33-46.
- Linde K, Ramirez G, Mulrow CD, Pauls A, Weidenhammer W, Melchart D. St John's wort for depression: an overview and meta-analysis of randomised clinical trials. BMJ 1996; 313: 253-258[Abstract/Free Full Text].
- Stevinson C, Ernst E. Hypericum for depression: an update of the clinical evidence. Eur Neuropharmacol (in press).
- Ernst E, Pittler MH. Ginkgo biloba for dementia: a systematic review of double-blind, placebo-controlled trials. Clin Drug Invest 1999; 17: 301-308.
- Wilt TJ, Iskani A, Stark G, McDonald R, Lan J, Murlow C. Saw palmetto extracts for treatment of benign prostatic hyperplasia. JAMA 1998; 280: 1604-1609[Abstract/Free Full Text].
- Pittler MH, Ernst E. Horse-chestnut seed extract for chronic venous insufficiency: a criteria-based systematic review. Arch Dermatol 1998; 134: 1356-1360[Abstract/Free Full Text].
- Müller WE, Singer A, Wonnemann M, Hafner U, Schäfer C. Hyperforin represents the neurotransmitter uptake inhibiting constituent of hypericum extract. Pharmacopsychiat 1998; 31(suppl): 16-21.
- Jowell T. Herbal medicines. In: House of Commons official report (Hansard) , 1999 March 26;426-27.
- Lord GM, Tagore R, Cook T, Gower P, Pusey CD. Nephropathy caused by Chinese herbs in the UK. Lancet 1999; 354: 481-482[CrossRef][Medline].
- Chrubasik S, Sporner F, Wink M. Zum Wirkstoffgehalt in Arzneimitteln aus Hapargophytum procumbens. Forsch Komplementärmed 1996; 3: 57-63.
- Keane FM, Munn SE, du Vivier AWP, Taylor NF, Higgins EM. Analysis of Chinese herbal creams prescribed for dermatological conditions. BMJ 1999; 318: 563-564[Abstract/Free Full Text].
- Janetzky K, Morreale AP. Probable interactions between warfarin and ginseng. Am J Health Syst Pharm 1997; 54: 692-693[Free Full Text].
- Ernst E. Possible interactions between synthetic and herbal medicinal products. Part 1: a systematic review of the indirect evidence. Perfusion (in press).
Notes
- ↑ E. Ernst, Herbal medicines: where is the evidence?, British Medical Journal, BMJ 2000;321:395-396 ( 12 August )
